Eco R1 Capital, LLC Apellis Pharmaceuticals, Inc. Transaction History
Eco R1 Capital, LLC
- $2.14 Billion
- Q4 2024
A detailed history of Eco R1 Capital, LLC transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Eco R1 Capital, LLC holds 11,890,843 shares of APLS stock, worth $216 Million. This represents 17.73% of its overall portfolio holdings.
Number of Shares
11,890,843
Previous 11,890,843
-0.0%
Holding current value
$216 Million
Previous $343 Million
10.64%
% of portfolio
17.73%
Previous 14.88%
Shares
11 transactions
Others Institutions Holding APLS
# of Institutions
299Shares Held
111MCall Options Held
2.63MPut Options Held
845K-
Avoro Capital Advisors LLC New York, NY12.2MShares$222 Million5.68% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$183 Million0.01% of portfolio
-
Morgan Stanley New York, NY9.63MShares$175 Million0.02% of portfolio
-
Black Rock Inc. New York, NY5.8MShares$105 Million0.01% of portfolio
-
State Street Corp Boston, MA4.53MShares$82.4 Million0.01% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $2B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...